Navigation Links
VetStem Regenerative Cell Therapy Helps Arthritic Sun Bear at the World-Famous San Diego Zoo
Date:3/27/2019

A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma has been providing autologous adipose-derived stem cell services to veterinarians across the United States and Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are osteoarthritis as well as bone and soft tissue injuries in the dog, cat, and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo to provide stem cell therapy for an arthritic sun bear named Francis.

In September 2018, VetStem CEO, Dr. Bob Harman, alongside local veterinary surgeon, Dr. Holly Mullen of VCA Emergency Animal Hospital and Referral Center, assisted San Diego Zoo senior veterinarian, Dr. Deena Brenner, to provide stem cell therapy for Francis. According to an article released in the March 2019 issue of ZooNooz, a San Diego Zoo publication, Francis is a 21-year-old sun bear who was diagnosed with arthritis in multiple joints. The worst of Francis’ arthritis was in his elbows and hips, which helped to explain why he was increasingly stiff and moving slower.

Dr. Holly Mullen, a VetStem-credentialed veterinarian who has been providing VetStem Regenerative Cell Therapy for over ten years, lent her expertise by administering Francis’ stem cell injections into his arthritic joints and also intravenously. After careful observation by several members of the Zoo staff, it was noted that Francis’ stiffness, gait, and activity level began to improve. By approximately two months after the stem cell therapy, Francis’ symptoms were reduced and only “mildly problematic.” In a 90-day follow up evaluation, it was reported that Francis continues to do well.

Vetstem founder and CEO, Dr Bob Harman, has authored several articles about the benefits of stem cell therapy. He also co-wrote a chapter on stem cell therapy for zoo animals with San Diego Zoo Safari Park veterinarian, Dr. Matthew Kinney, in the 9th edition of Fowler’s Zoo and Wild Animal Medicine Current Therapy. Though mesenchymal stem cell use in zoological medicine is in its infancy, successful cases like Francis’ help to broaden the potential applications of stem cell use as a therapeutic modality to improve the health of all animals.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-led Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_regenerative_cell_therapy_helps_arthritic_sun_bear_at_the_world_famous_san_diego_zoo/prweb16193066.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
2. VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
3. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services.
4. West Coast Bird Dog Champion Wins US Bird Dog Association Western States National Flushing Champion with the help of Stem Cell Therapy by VetStem.
5. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma, Announces the Addition of Dr Ross Rich as the Director of Clinical Development
6. VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering
7. VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities.
8. VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center.
9. VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour
10. VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to be a Guest Speaker at MSC 2015 Adult Stem Cell Therapy & Regenerative Medicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... engagement, and Carilion Clinic, a national leader in opioid treatment, announced today they ... care. , Mytonomy recently deployed its virtual care platform at the ...
(Date:5/31/2019)... City, California (PRWEB) , ... ... ... allowance of our patent applications from the USPTO providing proprietary interest to ... AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights ...
(Date:5/21/2019)... ... May 21, 2019 , ... ... today officially opened the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, ... Africa. The event, which is supported through a partnership with “Ethiopia Invest”, will ...
Breaking Biology Technology:
(Date:5/31/2019)... ... May 29, 2019 , ... ... Mac, Windows and mobile, announces the launch of version 13.1. The new version ... Android Management API, and supports Apple’s spring release functionality. Version 13.1 builds on ...
(Date:5/26/2019)... ... 2019 , ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat ... the United States by the Food and Drug Administration today. , The ... disorders in the United States and the second-ever approved treatment for SMA. , FDA ...
(Date:5/22/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... May ... ... premier manufacturer of custom built, helium-based leak testing instruments for the ... a formal partnership agreement with Industrial Production Processes (IPP) ...
Breaking Biology News(10 mins):